OptimizeRx (OPRX) Current Assets (2016 - 2025)
Historic Current Assets for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to $56.3 million.
- OptimizeRx's Current Assets rose 2006.99% to $56.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.3 million, marking a year-over-year increase of 2006.99%. This contributed to the annual value of $54.0 million for FY2024, which is 66.26% down from last year.
- Latest data reveals that OptimizeRx reported Current Assets of $56.3 million as of Q3 2025, which was up 2006.99% from $54.1 million recorded in Q2 2025.
- OptimizeRx's 5-year Current Assets high stood at $115.1 million for Q4 2021, and its period low was $46.0 million during Q2 2024.
- Moreover, its 5-year median value for Current Assets was $87.4 million (2023), whereas its average is $80.5 million.
- Its Current Assets has fluctuated over the past 5 years, first soared by 29793.67% in 2021, then plummeted by 4957.21% in 2024.
- Quarter analysis of 5 years shows OptimizeRx's Current Assets stood at $115.1 million in 2021, then fell by 14.37% to $98.6 million in 2022, then crashed by 44.88% to $54.3 million in 2023, then decreased by 0.66% to $54.0 million in 2024, then rose by 4.35% to $56.3 million in 2025.
- Its Current Assets stands at $56.3 million for Q3 2025, versus $54.1 million for Q2 2025 and $51.7 million for Q1 2025.